GlobeNewswire Inc | Jul 8, 2021 07:32AM EDT

July 08, 2021

CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff McDonough, M.D., president and chief executive officer, will present at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, at 9:00 a.m. ET.

A live webcast of the presentation will be available on the investor section of the companys website at investors.generationbio.com. A replay will be available there for 30 days following the event.

About Generation Bio

Generation Biois an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent diseases. The companys non-viral platform incorporates a proprietary, high-capacity DNA construct called closed-ended DNA, or ceDNA; a cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The platform is designed to enable multi-year durability from a single dose of ceDNA and to allow titration and redosing if needed. The ctLNP is designed to deliver large genetic payloads, including multiple genes, to specific tissues to address a wide range of indications. The companys efficient, scalable manufacturing process supports Generation Bios mission to extend the reach of gene therapy to more people, living with more diseases, in more places around the world.

For more information, please visitwww.generationbio.com.

Contact:

InvestorsMaren KillackeyGeneration Biomkillackey@generationbio.com541-646-2420

MediaAlicia WebbGeneration Bioawebb@generationbio.com847-254-4275

Stephanie SimonTenBridge Communicationsstephanie@tenbridgecommunications.com617-581-9333